188 related articles for article (PubMed ID: 34797850)
1. Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.
Jindra C; Hainisch EK; Rümmele A; Wolschek M; Muster T; Brandt S
PLoS One; 2021; 16(11):e0260155. PubMed ID: 34797850
[TBL] [Abstract][Full Text] [Related]
2. No evidence of bovine papillomavirus type 1 or 2 infection in healthy equids.
Pratscher B; Hainisch EK; Sykora S; Brandt S; Jindra C
Equine Vet J; 2019 Sep; 51(5):612-616. PubMed ID: 30560998
[TBL] [Abstract][Full Text] [Related]
3. Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.
Hainisch EK; Abel-Reichwald H; Shafti-Keramat S; Pratscher B; Corteggio A; Borzacchiello G; Wetzig M; Jindra C; Tichy A; Kirnbauer R; Brandt S
J Gen Virol; 2017 Feb; 98(2):230-241. PubMed ID: 28284277
[TBL] [Abstract][Full Text] [Related]
4. Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.
Harnacker J; Hainisch EK; Shafti-Keramat S; Kirnbauer R; Brandt S
J Gen Virol; 2017 Jun; 98(6):1329-1333. PubMed ID: 28635592
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterisation of bovine papillomavirus types 1 and 2 identified in equine sarcoids in Japan.
Yamashita-Kawanishi N; Chambers JK; Uchida K; Tobari Y; Yoshimura H; Yamamoto M; Yumoto N; Aoki H; Sugiura K; Higuchi T; Saito S; Haga T
Equine Vet J; 2021 Nov; 53(6):1199-1209. PubMed ID: 33300145
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles.
Mattil-Fritz S; Scharner D; Piuko K; Thönes N; Gissmann L; Müller H; Müller M
J Gen Virol; 2008 Jan; 89(Pt 1):138-147. PubMed ID: 18089737
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic analysis of a sarcoid outbreak involving 12 of 111 donkeys in Northern Italy.
Abel-Reichwald H; Hainisch EK; Zahalka S; Corteggio A; Borzacchiello G; Massa B; Merlone L; Nasir L; Burden F; Brandt S
Vet Microbiol; 2016 Nov; 196():85-92. PubMed ID: 27939161
[TBL] [Abstract][Full Text] [Related]
8. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes.
Shafti-Keramat S; Schellenbacher C; Handisurya A; Christensen N; Reininger B; Brandt S; Kirnbauer R
Virology; 2009 Oct; 393(1):1-6. PubMed ID: 19729180
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines.
Jindra C; Hainisch EK; Brandt S
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112681
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of infiltrating immune cells and bovine papillomavirus type 1 E2-positive cells in equine sarcoids.
Geisshüsler H; Marti E; Stoffel MH; Kühni K; Stojiljkovic A; von Tscharner C; Vidondo B; Gerber V; Koch C
Vet J; 2016 Oct; 216():45-52. PubMed ID: 27687925
[TBL] [Abstract][Full Text] [Related]
11. Intralesional bovine papillomavirus DNA loads reflect severity of equine sarcoid disease.
Haralambus R; Burgstaller J; Klukowska-Rötzler J; Steinborn R; Buchinger S; Gerber V; Brandt S
Equine Vet J; 2010 May; 42(4):327-31. PubMed ID: 20525051
[TBL] [Abstract][Full Text] [Related]
12. Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.
Hartl B; Hainisch EK; Shafti-Keramat S; Kirnbauer R; Corteggio A; Borzacchiello G; Tober R; Kainzbauer C; Pratscher B; Brandt S
J Gen Virol; 2011 Oct; 92(Pt 10):2437-2445. PubMed ID: 21715602
[TBL] [Abstract][Full Text] [Related]
13. Bovine Papillomavirus Type 1 or 2 Virion-Infected Primary Fibroblasts Constitute a Near-Natural Equine Sarcoid Model.
Hainisch EK; Jindra C; Reicher P; Miglinci L; Brodesser DM; Brandt S
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560661
[TBL] [Abstract][Full Text] [Related]
14. Evidence from a Series of 104 Equine Sarcoids Suggests That Most Sarcoids in New Zealand Are Caused by Bovine Papillomavirus Type 2, although Both BPV1 and BPV2 DNA Are Detectable in around 10% of Sarcoids.
Munday JS; Orbell G; Fairley RA; Hardcastle M; Vaatstra B
Animals (Basel); 2021 Oct; 11(11):. PubMed ID: 34827825
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.
Hainisch EK; Brandt S; Shafti-Keramat S; Van den Hoven R; Kirnbauer R
Equine Vet J; 2012 Jan; 44(1):107-11. PubMed ID: 21895749
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1.
Ashrafi GH; Piuko K; Burden F; Yuan Z; Gault EA; Müller M; Trawford A; Reid SWJ; Nasir L; Campo MS
J Gen Virol; 2008 Jan; 89(Pt 1):148-157. PubMed ID: 18089738
[TBL] [Abstract][Full Text] [Related]
17. Localization of Bovine papillomavirus in equine sarcoids and inflammatory skin conditions of horses using laser microdissection and two forms of DNA amplification.
Wobeser BK; Hill JE; Jackson ML; Kidney BA; Mayer MN; Townsend HG; Allen AL
J Vet Diagn Invest; 2012 Jan; 24(1):32-41. PubMed ID: 22362933
[TBL] [Abstract][Full Text] [Related]
18. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States.
Carr EA; Théon AP; Madewell BR; Griffey SM; Hitchcock ME
Am J Vet Res; 2001 May; 62(5):741-4. PubMed ID: 11341396
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of early and late bovine papillomavirus protein expression in equine sarcoids.
Wilson AD; Armstrong ELR; Gofton RG; Mason J; De Toit N; Day MJ
Vet Microbiol; 2013 Mar; 162(2-4):369-380. PubMed ID: 23123175
[TBL] [Abstract][Full Text] [Related]
20. Genomic sequences of bovine papillomaviruses in formalin-fixed sarcoids from Australian horses revealed by polymerase chain reaction.
Bloch N; Breen M; Spradbrow PB
Vet Microbiol; 1994 Jul; 41(1-2):163-72. PubMed ID: 7801519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
